Unrooting the Potential of Intranasal Administration of Curcumin as a Novel Asthma Controller by Alleviating Airway Inflammation

Main Article Content

Stella Kristi Triastari
Rifda Hanun Shalihah


Asthma is a chronic disease where air passage of the lung is inflamed and swollen. It is among major non-communicable diseases (NCDs) with more than 339 million sufferers and affects patients’ quality of life. Some drugs are currently used to control asthma symptoms, but it has its own economic burden. The aim of this literature review is to assess the potential use of curcumin to control asthma, as curcumin is cheaper and widely available in Indonesia. A total of eight literature was acquired after searching through Pubmed, Clinical Key, Scopus, Science Direct, Proquest, and Wiley Online databases with keywords including “intranasal”, “curcumin”, “asthma”, “inflammation”, and “airway”. Since inflammation is the most featured phenomenon in asthmatics that may lead to airway obstruction, it is important to lessen airway inflammation and thus control asthma. This mechanism can be seen in administration of curcumin, which although having a wide array of interaction with pathways, showcased to have anti-inflammatory effect which is beneficial in asthma. The anti-inflammatory effect of curcumin also negates other pathologic events relevant in asthma and appears to be preventive if administered before exacerbation. Intranasal administration displayed to be the most efficacious in asthma model, bested the efficacy of standard drugs. Lastly, no toxicity was observed by included studies.

Article Details

How to Cite
Naufal, M. A., Triastari, S. K. and Shalihah, R. H. (2021) “Unrooting the Potential of Intranasal Administration of Curcumin as a Novel Asthma Controller by Alleviating Airway Inflammation ”, Journal of Asian Medical Students’ Association. Kuala Lumpur, Malaysia, 9(1). doi: 10.52629/jamsa.v9i1.261.
Review Articles


WHO. Asthma [Internet]. Geneva: World Health Organization; 2020 May 20 [cited 2021 Feb 3]. Available from: https://www.who.int/news-room/fact-sheets/detail/asthma

Dharmage SC, Perret JL, Custovic A. Epidemiology of asthma in children and adults. Front Pediatr. 2019; 7: 246.

Unknown. Managing the cost of your medicines. UK: Asthma UK; 2020 [cited 2021 Feb 3]. Available from: https://www.asthma.org.uk/advice/inhalers-medicines-treatments/cost/

Reddel HK, Lembke K, Zwar NJ. The cost of asthma medicines. Aust Prescr. 2018; 41:34-6.

Bloom CI, de Preux L, Sheikh A, Quint JK. Health and cost impact of stepping down asthma medication for UK patients, 2001–2017: A population-based observational study. PLOS Med [Internet]. 2020 Jul [cited 2021 Feb 3]; 17(7): e1003145.

Nantiyanto ABD, Wiryani AS, Rusli A, Purnamasari A, Abdullah AG, Ana, Widiaty I, et al. Extraction of curcumin pigment from Indonesian local turmeric with its infrared spectra and thermal decomposition properties. IOP Conf. Ser.: Mater. Sci. Eng [Internet]. 2017 [cited 2021 Feb 3]; 180 012136. Available from: https://iopscience.iop.org/article/10.1088/1757-899X/180/1/012136/pdf

Subhashini, Chauhan PS, Dash D, Paul BN, Singh R. Intranasal curcumin ameliorates AIRWAY inflammation and obstruction by regulating MAPKinase Activation (P38, erk AND Jnk) and PROSTAGLANDIN D2 release in murine model of asthma. International Immunopharmacology. 2016;31:200–6.

Subhashini, Chauhan PS, Kumari S, Kumar JP, Chawla R, Dash D, et al. Intranasal curcumin and its evaluation in murine model of asthma. International Immunopharmacology. 2013;17(3):733–43.

Chauhan PS, Subhashini, Dash D, Singh R. Intranasal curcumin attenuates airway remodeling in murine model of chronic asthma. International Immunopharmacology. 2014;21(1):63–75.

Chauhan PS, Dash D, Singh R. Intranasal Curcumin Inhibits Pulmonary Fibrosis by Modulating Matrix Metalloproteinase-9 (MMP-9) in Ovalbumin-Induced Chronic Asthma. Inflammation. 2016;40(1):248–58.

Kumari A, Singh DK, Dash D, Singh R. Intranasal curcumin protects against LPS-induced airway remodeling by modulating toll-like receptor-4 (TLR-4) and matrix metalloproteinase-9 (MMP-9) expression via affecting MAP kinases in mouse model. Inflammopharmacology. 2018;27(4):731–48.

Chauhan PS, Singh DK, Dash D, Singh R. Intranasal curcumin regulates chronic asthma in mice by modulating NF-ĸB activation and MAPK signaling. Phytomedicine. 2018;51:29–38.

Kumari A, Dash D, Singh R. Lipopolysaccharide (LPS) exposure differently affects allergic asthma exacerbations and its amelioration by intranasal curcumin in mice. Cytokine. 2015;76(2):334–42.

Subhashini, Chauhan PS, Singh R. Ovalbumin-induced allergic inflammation lead to structural alterations in mouse model and protective effects of intranasal curcumin: A comparative study. Allergologia et Immunopathologia. 2016;44(3):246–56.

Bush A. Pathophysiological Mechanisms of Asthma. Frontiers in Pediatrics. 2019;7.

Sinyor B, Perez LC. Statpearls [Internet]. Treasure Island: StatPearls Publishing; 2020 Jul -. Pathophysiology Of Asthma [cited 2021 Feb 1]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK551579/

Doeing DC, Solway J. Airway smooth muscle in the pathophysiology and treatment of asthma. Journal of Applied Physiology. 2013;114(7):834–43.

Hough KP, Curtiss ML, Blain TJ, Liu R-M, Trevor J, Deshane JS, et al. Airway Remodeling in Asthma. Frontiers in Medicine. 2020;7.

Fehrenbach H, Wagner C, Wegmann M. Airway remodeling in asthma: what really matters. Cell and Tissue Research. 2017;367(3):551–69.

Ojiaku CA, Yoo EJ, Panettieri RA. Transforming Growth Factor β1 Function in Airway Remodeling and Hyperresponsiveness. The Missing Link? American Journal of Respiratory Cell and Molecular Biology. 2017;56(4):432–42.

Bonser L, Erle D. Airway Mucus and Asthma: The Role of MUC5AC and MUC5B. Journal of Clinical Medicine. 2017;6(12):112.

Saglani S, Lloyd CM. Novel concepts in airway inflammation and remodelling in asthma. European Respiratory Journal. 2015;46(6):1796–804.

Quirt J, Hildebrand KJ, Mazza J, Noya F, Kim H. Asthma. Allergy, Asthma & Clinical Immunology. 2018;14(S2).

Ishmael FT. The inflammatory response in the pathogenesis of asthma. J. Am. Osteopath. Assoc. 2011 Nov;111(11).

Zainab R, Akram M, Daniyal M, Riaz M. Awareness and Current Therapeutics of Asthma. Dose-Response. 2019;17(3):155932581987090.

AHRQ. Intermittent inhaled corticosteroids and long-acting muscarinic antagonists for asthma [Internet]. MD: AHRQ; 2017 Oct [cited 2021 Feb 3]. Available from: https://effectivehealthcare.ahrq.gov/sites/default/files/cer-194-evidence-summary-corticosteroids-asthma_2.pdf

Liang TZ, Chao JH. Inhaled corticosteroids [Internet]. Edition unknown. Treasure Island (FL): StatPearls Publishing; 2020 Jan [cited 2021 Feb 3]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK470556/

Barnes PJ. Inhaled corticosteroids. Pharmaceuticals (Basel). 2010 Mar; 3(3): 514–540.

Billington CK, Penn RB, Hall IP. β2-agonists. Handb Exp Pharmacol. 2017; 237: 23–40.

Hsu E, Bajaj T. Beta 2 agonists[Internet]. Edition unknown. Treasure Island (FL): StatPearls Publishing; 2020 Jan [cited 2021 Feb 3]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK542249/

Unknown. Beta2-agonists (bronchodilators) definition [Internet]. WI: AAAAI; date unknown [cited 2021 Feb 3]. Available from: https://www.aaaai.org/conditions-and-treatments/conditions-dictionary/beta2-agonists-(bronchodilators)

Unknown. AAAAI allergy & asthma medication guide [Internet]. WI: AAAAI; 2020 Nov [cited 2021 Feb 3]. Available from: https://www.aaaai.org/conditions-and-treatments/drug-guide/long-acting-bronchodilators-(labas)

Hewlings SJ, Kalman DS. Curcumin: A review of its’ effects on human health. Foods. 2017 Oct; 6(10): 92.

Noorafshan A, Ashkani-Esfahani S. A review of therapeutic effects of curcumin. Curr Pharm Des. 2013; 19(11):2032-46.

Chen L, Deng H, Cui H, Fang J, Zuo Z, Deng J, et al. Inflammatory responses and inflammation-associated diseases in organs. Oncotarget. 2018 Jan 23; 9(6): 7204–18.

Chauhan PS, Jaiswal A, Subashini, Singh R. Combination therapy with curcumin alone plus piperine ameliorates ovalbumin-induced chronic asthma in mice. Inflammation. 2018 Oct; 41(5):1922-33.

Cho YS, Moon H. The role of oxidative stress in the pathogenesis of asthma. Allergy Asthma Immunol Res. 2010 Jul; 2(3): 183–7.

Marx D, Williams G, Matthias B. Intranasal drug administration — an attractive delivery route for some drugs. In: Vallisuta O, Olimat S, editors. Drug discovery and development - from molecules to medicine. 1st ed. Place unknown: IntechOpen; 2015 June. p. 299-320.

Kumari A, Dash D, Singh R. Curcumin inhibits lipopolysaccharide (LPS)-induced endotoxemia and airway inflammation through modulation of sequential release of inflammatory mediators (TNF-a and TGF-β1) in murine model. Inflammopharmacology. 2017 Jun;25(3):329-341.

Listyana NH. Analisis keterkaitan produksi kunyit di indonesia dan faktor-faktor yang mempengaruhinya. Journal of Sustainable Agriculture. 2018; 33(2): 106-114

The World Bank. The world bank in indonesia. 2020 Oct 1 [cited 2021 Feb 6]. Available from: https://www.worldbank.org/en/country/indonesia/overview

Wu S, Xiao D. Effect of curcumin on nasal symptoms and airflow in patients with perennial allergic rhinitis. Allergy Asthma Immunol. 2016 Dec;117(6):697-702.e1.

Manarin G, Anderson D, Silva JME, Coppede JD, Roxo-Junior P, Pereira AMS et al. Curcuma longa L. ameliorates asthma control in children and adolescents: A randomized, double-blind, controlled trial. J Ethnopharmacol. 2019 Jun 28;238:111882